Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Hyperpolarised 13C MRI: a new horizon for non-invasive diagnosis of aggressive breast cancer.

Abeyakoon O, Latifoltojar A, Gong F, Papoutsaki MV, Chowdhury R, Glaser M, Jeraj H, Awais R, Holt C, Twyman F, Arstad E, Gadian DG, Atkinson D, Comment A, O'Callaghan J, Smith L, Beeston T, Clemente J, Patani N, Stein R, Yuneva M, Szabadkai G, Halligan S, Punwani S.

BJR Case Rep. 2019 May 15;5(3):20190026. doi: 10.1259/bjrcr.20190026. eCollection 2019 Sep.

2.

Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes.

Sellers K, Allen TD, Bousamra M 2nd, Tan J, Méndez-Lucas A, Lin W, Bah N, Chernyavskaya Y, MacRae JI, Higashi RM, Lane AN, Fan TW, Yuneva MO.

Br J Cancer. 2019 Jul;121(1):51-64. doi: 10.1038/s41416-019-0464-z. Epub 2019 May 22.

3.

Low catalytic activity is insufficient to induce disease pathology in triosephosphate isomerase deficiency.

Segal J, Mülleder M, Krüger A, Adler T, Scholze-Wittler M, Becker L, Calzada-Wack J, Garrett L, Hölter SM, Rathkolb B, Rozman J, Racz I, Fischer R, Busch DH, Neff F, Klingenspor M, Klopstock T, Grüning NM, Michel S, Lukaszewska-McGreal B, Voigt I, Hartmann L, Timmermann B, Lehrach H, Wolf E, Wurst W, Gailus-Durner V, Fuchs H, H de Angelis M, Schrewe H, Yuneva M, Ralser M.

J Inherit Metab Dis. 2019 Sep;42(5):839-849. doi: 10.1002/jimd.12105. Epub 2019 Jun 11.

PMID:
31111503
4.

Correction: Hopefully devoted to Q: targeting glutamine addiction in cancer.

Still ER, Yuneva MO.

Br J Cancer. 2019 Apr;120(9):957. doi: 10.1038/s41416-019-0432-7.

5.

Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity.

Vriens K, Christen S, Parik S, Broekaert D, Yoshinaga K, Talebi A, Dehairs J, Escalona-Noguero C, Schmieder R, Cornfield T, Charlton C, Romero-Pérez L, Rossi M, Rinaldi G, Orth MF, Boon R, Kerstens A, Kwan SY, Faubert B, Méndez-Lucas A, Kopitz CC, Chen T, Fernandez-Garcia J, Duarte JAG, Schmitz AA, Steigemann P, Najimi M, Hägebarth A, Van Ginderachter JA, Sokal E, Gotoh N, Wong KK, Verfaillie C, Derua R, Munck S, Yuneva M, Beretta L, DeBerardinis RJ, Swinnen JV, Hodson L, Cassiman D, Verslype C, Christian S, Grünewald S, Grünewald TGP, Fendt SM.

Nature. 2019 Feb;566(7744):403-406. doi: 10.1038/s41586-019-0904-1. Epub 2019 Feb 6.

6.

The big picture: exploring the metabolic cross-talk in cancer.

Schulze A, Yuneva M.

Dis Model Mech. 2018 Aug 24;11(8). pii: dmm036673. doi: 10.1242/dmm.036673.

7.

De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition.

Tarrado-Castellarnau M, de Atauri P, Tarragó-Celada J, Perarnau J, Yuneva M, Thomson TM, Cascante M.

Mol Syst Biol. 2017 Oct 4;13(10):940. doi: 10.15252/msb.20167321.

8.

Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.

Méndez-Lucas A, Li X, Hu J, Che L, Song X, Jia J, Wang J, Xie C, Driscoll PC, Tschaharganeh DF, Calvisi DF, Yuneva M, Chen X.

Cancer Res. 2017 Aug 15;77(16):4355-4364. doi: 10.1158/0008-5472.CAN-17-0498. Epub 2017 Jun 19.

9.

Hopefully devoted to Q: targeting glutamine addiction in cancer.

Still ER, Yuneva MO.

Br J Cancer. 2017 May 23;116(11):1375-1381. doi: 10.1038/bjc.2017.113. Epub 2017 Apr 25. Review. Erratum in: Br J Cancer. 2019 Apr;120(9):957.

10.

MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.

Sancho P, Burgos-Ramos E, Tavera A, Bou Kheir T, Jagust P, Schoenhals M, Barneda D, Sellers K, Campos-Olivas R, Graña O, Viera CR, Yuneva M, Sainz B Jr, Heeschen C.

Cell Metab. 2015 Oct 6;22(4):590-605. doi: 10.1016/j.cmet.2015.08.015. Epub 2015 Sep 10.

11.

Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation.

Sellers K, Fox MP, Bousamra M 2nd, Slone SP, Higashi RM, Miller DM, Wang Y, Yan J, Yuneva MO, Deshpande R, Lane AN, Fan TW.

J Clin Invest. 2015 Feb;125(2):687-98. doi: 10.1172/JCI72873. Epub 2015 Jan 20.

12.

Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.

Timmerman LA, Holton T, Yuneva M, Louie RJ, Padró M, Daemen A, Hu M, Chan DA, Ethier SP, van 't Veer LJ, Polyak K, McCormick F, Gray JW.

Cancer Cell. 2013 Oct 14;24(4):450-65. doi: 10.1016/j.ccr.2013.08.020. Epub 2013 Oct 3.

13.

SCD1 Expression is dispensable for hepatocarcinogenesis induced by AKT and Ras oncogenes in mice.

Li L, Wang C, Calvisi DF, Evert M, Pilo MG, Jiang L, Yuneva M, Chen X.

PLoS One. 2013 Sep 19;8(9):e75104. doi: 10.1371/journal.pone.0075104. eCollection 2013.

14.

Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.

Wang B, Hsu SH, Wang X, Kutay H, Bid HK, Yu J, Ganju RK, Jacob ST, Yuneva M, Ghoshal K.

Hepatology. 2014 Feb;59(2):555-66. doi: 10.1002/hep.26712. Epub 2013 Dec 20.

15.

The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

Yuneva MO, Fan TW, Allen TD, Higashi RM, Ferraris DV, Tsukamoto T, Matés JM, Alonso FJ, Wang C, Seo Y, Chen X, Bishop JM.

Cell Metab. 2012 Feb 8;15(2):157-70. doi: 10.1016/j.cmet.2011.12.015.

16.

Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase.

Yang D, Liu H, Goga A, Kim S, Yuneva M, Bishop JM.

Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13836-41. doi: 10.1073/pnas.1008366107. Epub 2010 Jul 19.

17.
18.

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells.

Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y.

J Cell Biol. 2007 Jul 2;178(1):93-105.

19.

Protective effect of carnosine on Cu,Zn-superoxide dismutase during impaired oxidative metabolism in the brain in vivo.

Stvolinskii SL, Fedorova TN, Yuneva MO, Boldyrev AA.

Bull Exp Biol Med. 2003 Feb;135(2):130-2.

PMID:
12802415
20.

Na/K-ATPase regulates intracellular ROS level in cerebellum neurons.

Boldyrev A, Bulygina E, Yuneva M, Schoner W.

Ann N Y Acad Sci. 2003 Apr;986:519-21. No abstract available.

PMID:
12763874
21.

Antioxidant systems in tissues of senescence accelerated mice.

Boldyrev AA, Yuneva MO, Sorokina EV, Kramarenko GG, Fedorova TN, Konovalova GG, Lankin VZ.

Biochemistry (Mosc). 2001 Oct;66(10):1157-63.

22.

Carnosine as a potential anti-senescence drug.

Gallant S, Semyonova M, Yuneva M.

Biochemistry (Mosc). 2000 Jul;65(7):866-8.

Supplemental Content

Loading ...
Support Center